메뉴 건너뛰기




Volumn 20, Issue 9, 2012, Pages 2912-2922

Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents

Author keywords

Cyclooxygenase; Docking; Isoxazolo 4,5 d pyridazin 4 (5H) one; Lipoxygenase; NSAID

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 7 (4 METHOXYBENZYL) 3 METHYL 5 [[5 (ETHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 METHOXYBENZYL) 3 METHYL 5 [[5 (METHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 METHOXYBENZYL) 3 METHYL 5 [[5 (PHENYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 METHOXYBENZYL) 5 [(4 ETHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 METHOXYBENZYL) 5 [(4 METHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 METHOXYBENZYL) 5 [(4 PHENYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 3 METHYL 5 [[5 (ETHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 3 METHYL 5 [[5 (METHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 3 METHYL 5 [[5 (PHENYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 5 [(4 ETHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 5 [(4 METHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 (4 NITROBENZYL) 5 [(4 PHENYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLO[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 3 METHYL 5 [[5 (ETHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 3 METHYL 5 [[5 (METHYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 3 METHYL 5 [[5 (PHENYLAMINO) 1,3,4 THIADIAZOL 2 YL]METHYL]ISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 5 [(4 ETHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 5 [(4 METHYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; 7 BENZYL 5 [(4 PHENYL 5 THIOXO 4,5 DIHYDRO 1H 1,2,4 TRIAZOL 3 YL)METHYL] 3 METHYLISOXAZOLOL[4,5 D]PYRIDAZIN 4(5H) ONE; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; CAFFEIC ACID; CYCLOOXYGENASE 2; IBUPROFEN; ISOXAZOLO[4,5 D]PYRIDAZIN 4 (5H) ONE DERIVATIVE; PYRIDAZINE DERIVATIVE; UNCLASSIFIED DRUG; ZILEUTON;

EID: 84859887528     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.03.021     Document Type: Article
Times cited : (49)

References (51)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.